ACE and Hyperkalemia: Although it is possible that many patients were not prescribed these medications due to low eGFR or side effects, such as hyperkalemia in the case of ACE inhibitors and ARBs, or myopathy in the case of statins, this finding may serve as a target for future quality improvement initiatives in our institution.